Great Valley Advisor Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$594K Sell
2,395
-74
-3% -$15.9K 0.01% 662
2026
Q1
$496K Buy
2,469
+537
+28% +$111K 0.01% 690
2025
Q4
$399K Sell
1,932
-1,886
-49% -$377K 0.01% 694
2025
Q3
$684K Buy
3,818
+271
+8% +$46.2K 0.01% 562
2025
Q2
$573K Sell
3,547
-138
-4% -$22K 0.01% 577
2025
Q1
$627K Buy
+3,685
New +$640K 0.01% 541
2024
Q1
Sell
-44,685
Closed -$7.06M 760
2023
Q4
$7.06M Sell
44,685
-1,359
-3% -$195K 0.25% 106
2023
Q3
$6.74M Buy
46,044
+17,248
+60% +$2.63M 0.28% 95
2023
Q2
$4.41M Buy
28,796
+90
+0.3% +$14K 0.18% 137
2023
Q1
$4.45M Buy
28,706
+27,071
+1,656% +$4.25M 0.21% 126
2022
Q4
$252K Sell
1,635
-1,407
-46% -$208K 0.01% 598
2022
Q3
$402K Sell
3,042
-94
-3% -$13.2K 0.02% 470
2022
Q2
$425K Sell
3,136
-1,306
-29% -$180K 0.02% 461
2022
Q1
$714K Sell
4,442
-874
-16% -$129K 0.04% 325
2021
Q4
$881K Hold
5,316
0.05% 280
2021
Q3
$883K Sell
5,316
-266
-5% -$45.4K 0.06% 261
2021
Q2
$901K Buy
5,582
+58
+1% +$9.58K 0.07% 252
2021
Q1
$886K Buy
5,524
+9
+0.2% +$1.54K 0.09% 211
2020
Q4
$926K Sell
5,515
-626
-10% -$102K 0.1% 191
2020
Q3
$966K Buy
6,141
+318
+5% +$52K 0.12% 171
2020
Q2
$976K Buy
+5,823
New +$914K 0.16% 151

Other funds holding FBT

Great Valley Advisor Group's FBT Position: Q2 2026 in Review

Great Valley Advisor Group reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 3% in Q2 2026, selling an estimated $15.9K and leaving 2,395 shares worth $594K. The position accounts for 0.01% of the portfolio, ranked #662.

Great Valley Advisor Group first reported a position in FBT in Q2 2020 and has held it in 21 quarters since. The position peaked at $7.06M in Q4 2023. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Great Valley Advisor Group held 2,395 shares of First Trust NYSE Arca Biotechnology Index Fund worth $594K as of Q2 2026.
  • Great Valley Advisor Group sold 74 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $15.9K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Great Valley Advisor Group's portfolio in Q2 2026, its #662 holding.
  • Great Valley Advisor Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2020 and has held it in 21 quarters since.
  • Great Valley Advisor Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $7.06M in Q4 2023.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Great Valley Advisor Group's 13F filing for Q2 2026, filed 10 Aug 2026.